News

Cardiac Screening Is Not Routine Before Prescribing Stimulants


 

FROM PEDIATRICS

The study was limited by the lower-than-expected response rate, the lack of information about the resources available in each practice, and the lack of perspective from families. But the study is the first to ask pediatricians about this topic specifically, and the findings reinforce the ongoing controversy over the potential cardiac risks associated with stimulant use by children with ADHD, Dr. Leslie and colleagues noted.

Dr. Leslie and colleagues reported having no relevant financial disclosures. The study was funded by the National Institutes of Health.

Pages

Recommended Reading

PALLAS Trial Demotes Dronedarone for Atrial Fibrillation
MDedge Family Medicine
Excessive Vitamin D Intake May Elevate A Fib Risk
MDedge Family Medicine
Bringing Back Kids in Cardiopulmonary Arrest
MDedge Family Medicine
FDA Investigating Reports of Bleeding Events With Pradaxa
MDedge Family Medicine
GI Events Elevated in Newly Diagnosed Atrial Fib Patients
MDedge Family Medicine
FDA Revamps Multaq Label in Wake of PALLAS Mortality Data
MDedge Family Medicine
Patient Died Soon After Taking MS Drug Fingolimod
MDedge Family Medicine
Dabigatran Tied to Increase in Heart Attack Risk
MDedge Family Medicine
New Stroke-Prevention Drugs Spur A-Fib Guides
MDedge Family Medicine
ASSERT: Subclinical Atrial Fib Boosts Stroke Risk
MDedge Family Medicine